Literature DB >> 16564009

The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin.

Wensheng Wei1, Quan Lu, G Jilani Chaudry, Stephen H Leppla, Stanley N Cohen.   

Abstract

Toxins produced by Bacillus anthracis and other microbial pathogens require functions of host cell genes to yield toxic effects. Here we show that low density lipoprotein receptor-related protein 6 (LRP6), previously known to be a coreceptor for the Wnt signaling pathway, is required for anthrax toxin lethality in mammalian cells. Downregulation of LRP6 or coexpression of a truncated LRP6 dominant-negative peptide inhibited cellular uptake of complexes containing the protective antigen (PA) carrier of anthrax toxin moieties and protected targeted cells from death, as did antibodies against epitopes in the LRP6 extracellular domain. Fluorescence microscopy and biochemical analyses showed that LRP6 enables toxin internalization by interacting at the cell surface with PA receptors TEM8/ATR and/or CMG2 to form a multicomponent complex that enters cells upon PA binding. Our results, which reveal a previously unsuspected biological role for LRP6, identify LRP6 as a potential target for countermeasures against anthrax toxin lethality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16564009     DOI: 10.1016/j.cell.2005.12.045

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  59 in total

Review 1.  Anthrax lethal and edema toxins in anthrax pathogenesis.

Authors:  Shihui Liu; Mahtab Moayeri; Stephen H Leppla
Journal:  Trends Microbiol       Date:  2014-03-27       Impact factor: 17.079

2.  Polyvalent inhibitors of anthrax toxin that target host receptors.

Authors:  Saleem Basha; Prakash Rai; Vincent Poon; Arundhati Saraph; Kunal Gujraty; Mandy Y Go; Skanda Sadacharan; Mia Frost; Jeremy Mogridge; Ravi S Kane
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

3.  Human genetic variation altering anthrax toxin sensitivity.

Authors:  Mikhail Martchenko; Sophie I Candille; Hua Tang; Stanley N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

4.  Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.

Authors:  Ming Yan; Michael H Roehrl; Emre Basar; Julia Y Wang
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

5.  The cytoplasmic domain of anthrax toxin receptor 1 affects binding of the protective antigen.

Authors:  Mandy Y Go; Edith M C Chow; Jeremy Mogridge
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

6.  Micropatterned macrophage analysis reveals global cytoskeleton constraints induced by Bacillus anthracis edema toxin.

Authors:  Yannick Trescos; Emilie Tessier; Clémence Rougeaux; Pierre L Goossens; Jean-Nicolas Tournier
Journal:  Infect Immun       Date:  2015-05-26       Impact factor: 3.441

7.  High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells.

Authors:  Yuexin Zhou; Shiyou Zhu; Changzu Cai; Pengfei Yuan; Chunmei Li; Yanyi Huang; Wensheng Wei
Journal:  Nature       Date:  2014-04-09       Impact factor: 49.962

8.  Phenotype-based identification of host genes required for replication of African swine fever virus.

Authors:  Annie C Y Chang; Laszlo Zsak; Yanan Feng; Ronen Mosseri; Quan Lu; Paul Kowalski; Aniko Zsak; Thomas G Burrage; John G Neilan; Gerald F Kutish; Zhiqiang Lu; Will Laegreid; Daniel L Rock; Stanley N Cohen
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

9.  Inhibition of anthrax protective antigen outside and inside the cell.

Authors:  Marina V Backer; Vimal Patel; Brian T Jehning; Kevin P Claffey; Vladimir A Karginov; Joseph M Backer
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

10.  CCT chaperonin complex is required for efficient delivery of anthrax toxin into the cytosol of host cells.

Authors:  Louise H Slater; Erik C Hett; Anne E Clatworthy; Kevin G Mark; Deborah T Hung
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.